Your browser doesn't support javascript.
loading
Variants in PHF8 cause a spectrum of X-linked neurodevelopmental disorders and facial dysmorphology.
Sobering, Andrew K; Bryant, Laura M; Li, Dong; McGaughran, Julie; Maystadt, Isabelle; Moortgat, Stephanie; Graham, John M; van Haeringen, Arie; Ruivenkamp, Claudia; Cuperus, Roos; Vogt, Julie; Morton, Jenny; Brasch-Andersen, Charlotte; Steenhof, Maria; Hansen, Lars Kjærsgaard; Adler, Élodie; Lyonnet, Stanislas; Pingault, Veronique; Sandrine, Marlin; Ziegler, Alban; Donald, Tyhiesia; Nelson, Beverly; Holt, Brandon; Petryna, Oleksandra; Firth, Helen; McWalter, Kirsty; Zyskind, Jacob; Telegrafi, Aida; Juusola, Jane; Person, Richard; Bamshad, Michael J; Earl, Dawn; Tsai, Anne Chun-Hui; Yearwood, Katherine R; Marco, Elysa; Nowak, Catherine; Douglas, Jessica; Hakonarson, Hakon; Bhoj, Elizabeth J.
Afiliação
  • Sobering AK; AU/UGA Medical Partnership, Department of Basic Sciences, University of Georgia Health Sciences Campus, Athens, GA 30602, USA.
  • Bryant LM; St. George's University, Department of Biochemistry, St. George's, Grenada, West Indies.
  • Li D; Windward Islands Research and Education Foundation, True Blue, St. George's, Grenada, West Indies.
  • McGaughran J; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Maystadt I; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Moortgat S; Genetic Health Queensland, RBWH, Brisbane and The University of Queensland School of Medicine, Brisbane, QLD 4029, Australia.
  • Graham JM; Centre de Génétique Humaine, Institut de Pathologie et de Génétique, 6041 Gosselies, Belgium.
  • van Haeringen A; Centre de Génétique Humaine, Institut de Pathologie et de Génétique, 6041 Gosselies, Belgium.
  • Ruivenkamp C; Medical Genetics, Department of Pediatrics, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048, USA.
  • Cuperus R; Leiden University Medical Center, 9600, 2300 RC Leiden, the Netherlands.
  • Vogt J; Leiden University Medical Center, 9600, 2300 RC Leiden, the Netherlands.
  • Morton J; Juliana Children's Hospital, HAGA Medical Center, The Hague, the Netherlands.
  • Brasch-Andersen C; Birmingham Women's and Children's NHS Foundation Trust, Birmingham Women's Hospital, Birmingham B15 2TG, UK.
  • Steenhof M; West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women's Hospital NHS Foundation Trust, Birmingham B15 2TG, UK.
  • Hansen LK; Department of Clinical Genetics, Odense University Hospital, Odense 5000, Denmark.
  • Adler É; Human Genetics, Department of Clinical Research, University of Southern Denmark, Odense 5000, Denmark.
  • Lyonnet S; Department of Clinical Genetics, Odense University Hospital, Odense 5000, Denmark.
  • Pingault V; Department of Paediatrics, Odense University Hospital, Odense 5000, Denmark.
  • Sandrine M; Fédération de Médecine Génomique and Imagine Institute, Université de Paris, Hôpital Necker-Enfants Malades, APHP, 75015 Paris, France.
  • Ziegler A; Fédération de Médecine Génomique and Imagine Institute, Université de Paris, Hôpital Necker-Enfants Malades, APHP, 75015 Paris, France.
  • Donald T; Fédération de Médecine Génomique and Imagine Institute, Université de Paris, Hôpital Necker-Enfants Malades, APHP, 75015 Paris, France.
  • Nelson B; Reference Center for Genetic Deafness, Fédération de Médecine Génomique and Imagine Institute, Université de Paris, Hôpital Necker-Enfants Malades, APHP, 75015 Paris, France.
  • Holt B; Reference Center for Genetic Deafness, Fédération de Médecine Génomique and Imagine Institute, Université de Paris, Hôpital Necker-Enfants Malades, APHP, 75015 Paris, France.
  • Petryna O; Clinical Teaching Unit, St. George's University School of Medicine, St. George's, Grenada, West Indies.
  • Firth H; Clinical Teaching Unit, St. George's University School of Medicine, St. George's, Grenada, West Indies.
  • McWalter K; Department of Anatomical Sciences, St. George's University, Grenada, West Indies.
  • Zyskind J; Hackensack University Ocean Medical Center, Department of Psychiatry, Hackensack, NJ 08724, USA.
  • Telegrafi A; Department of Clinical Genetics, Cambridge University Hospitals, Box 134, Cambridge CB2 0QQ, UK.
  • Juusola J; Clinical Genomics, GeneDx, Gaithersburg, MD 20877, USA.
  • Person R; Clinical Genomics, GeneDx, Gaithersburg, MD 20877, USA.
  • Bamshad MJ; Clinical Genomics, GeneDx, Gaithersburg, MD 20877, USA.
  • Earl D; Clinical Genomics, GeneDx, Gaithersburg, MD 20877, USA.
  • Tsai AC; Seattle Children's Hospital, Seattle, WA 98105, USA.
  • Yearwood KR; Departments of Pediatrics and Genome Sciences, University of Washington, Seattle, WA 98195, USA.
  • Marco E; Brotman-Baty Institute, Seattle, WA 98195, USA.
  • Nowak C; Seattle Children's Hospital, Seattle, WA 98105, USA.
  • Hakonarson H; University of Oklahoma, Section of Genetics, 800 Stanton L Young Boulevard, Oklahoma City, OK 73117, USA.
  • Bhoj EJ; University Health Services, St. George's University, Grenada, West Indies.
HGG Adv ; 3(3): 100102, 2022 Jul 14.
Article em En | MEDLINE | ID: mdl-35469323
ABSTRACT
Loss-of-function variants in PHD Finger Protein 8 (PHF8) cause Siderius X-linked intellectual disability (ID) syndrome, hereafter called PHF8-XLID. PHF8 is a histone demethylase that is important for epigenetic regulation of gene expression. PHF8-XLID is an under-characterized disorder with only five previous reports describing different PHF8 predicted loss-of-function variants in eight individuals. Features of PHF8-XLID include ID and craniofacial dysmorphology. In this report we present 16 additional individuals with PHF8-XLID from 11 different families of diverse ancestry. We also present five individuals from four different families who have ID and a variant of unknown significance in PHF8 with no other explanatory variant in another gene. All affected individuals exhibited developmental delay and all but two had borderline to severe ID. Of the two who did not have ID, one had dyscalculia and the other had mild learning difficulties. Craniofacial findings such as hypertelorism, microcephaly, elongated face, ptosis, and mild facial asymmetry were found in some affected individuals. Orofacial clefting was seen in three individuals from our cohort, suggesting that this feature is less common than previously reported. Autism spectrum disorder and attention deficit hyperactivity disorder, which were not previously emphasized in PHF8-XLID, were frequently observed in affected individuals. This series expands the clinical phenotype of this rare ID syndrome caused by loss of PHF8 function.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: HGG Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: HGG Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos